References

Rheumatoid arthritis–interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality

10.3899/jrheum.171315 · 2019 · External reference

Rheumatoid arthritis-interstitial lung disease-associated mortality

10.1164/rccm.201004-0622oc · 2011 · External reference

ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease

10.1183/13993003.02533-2024 · 2026 · External reference

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases

10.1002/acr.25347 · 2024 · External reference

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

10.1093/rheumatology/kes289 · 2013 · External reference

Idiopathic pulmonary fibrosis: data-driven textural analysis of extent of fibrosis at baseline and 15-month follow-up

10.1148/radiol.2017161177 · 2017 · External reference

Deep learning–based fibrosis extent on computed tomography predicts outcome of fibrosing interstitial lung disease independent of visually assessed computed tomography pattern

10.1513/annalsats.202301-084oc · 2024 · External reference

Quantitative CT scan analysis in rheumatoid arthritis-related interstitial lung disease

10.1016/j.chest.2024.10.052 · 2025 · External reference

Prospective identification of subclinical interstitial lung disease in a rheumatoid arthritis cohort is associated with the MUC5B promoter variant

10.1164/rccm.202109-2087le · 2022 · External reference

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

10.1016/s2213-2600(22)00260-0 · 2023 · External reference